Reviewing a two-year trial that gave patients access to novel medications and therapeutic options.
Guernsey States decided the healthcare system should provide a comparable range of services to the NHS in 2020.
Around a third of NICE-approved medical procedures at the time were only accessible locally if patients paid for them privately.
The government is currently assessing its effectiveness and seeking public input.
NICE recommendations are frequently accepted and funded throughout the NHS, but not in Guernsey.
When the trial was announced, the health committee deemed the local drug and treatment shortage "unacceptable.".
For a number of serious medical conditions like cancer, diabetes, and MS., it was anticipated to cost £14 million and make 93 new treatments available.
The majority of treatments involve taking medications, but they can also involve using other tools, techniques, or having surgery.
A "lived experience.".
About 3000 patients were expected to gain from it, either by living longer, experiencing fewer side effects, or having a higher quality of life.
An extensive clinical and financial analysis of the effects of the new treatments will be carried out independently by a company called Solutions for Public Health.
Input from patients or their families is also wanted.
That portion of the review is being coordinated by the independent panel CareWatch.
"We are keen to hear, understand, and pass on evidence of the lived experience from patients or their families, before, during, and after a new treatment was made available," said Mike Reed, a panel member. ".
The group also wants to look into any remaining gaps in the local resources. .
"Some medications and treatments are still deemed to be too expensive and are still out of reach for some people.
We'd also like to know if patients have been refused access to a new treatment, he added, so we can identify any areas where such access is still restricted.
